Prevalence and incidence of chronic kidney disease stage G5 in Japan

Clinical and Experimental Nephrology

Volumn 19, Issue 1, 2015, Pages 54-64

  Yamagata, Kunihiro ^a   Yagisawa, Takashi ^b   Nakai, Shigeru ^c   Nakayama, Masaaki ^d   Imai, Enyu ^e   Hattori, Motoshi ^f   Iseki, Kunitoshi ^g   Akiba, Takashi ^f  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e Imai Nakayama Temple Clinic   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Chronic kidney disease; End stage kidney disease; Renal replacement therapy

Indexed keywords

HUMAN; INCIDENCE; JAPAN; KIDNEY FAILURE, CHRONIC; PREVALENCE; REGISTER; RENAL REPLACEMENT THERAPY; STATISTICS AND NUMERICAL DATA;

HUMANS; INCIDENCE; JAPAN; KIDNEY FAILURE, CHRONIC; PREVALENCE; REGISTRIES; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 84928322816     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-0978-x     Document Type: Review

References (21)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–59.
2. Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial. 2012;16:483–521.
3. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13(Suppl 1):S37–40.
4. System, USRD: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2009 USRDS Annual data report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009.
5. JSCRT, JST: Annual Progress report from the Japanese Renal Transplant Registry, 2010. Part III: results from 2009 Recipient Follow-up Survey. Transplantation 2010;45:608–630 (in Japanese).
6. Foley RN, Collins AJ. The USRDS: what you need to know about what it can and can’t tell us about ESRD. Clin J Am Soc Nephrol. 2013;8:845–51.
7. Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial. 2010;14:505–40.
8. Iseki K, Nakai S, Yamagata K, Tsubakihara Y. Tachycardia as a predictor of poor survival in chronic haemodialysis patients. Nephrol Dial Transplant. 2011;26:963–9.
9. Yamagata K, Nakai S, Masakane I, Hanafusa N, Iseki K, Tsubakihara Y. Ideal timing and predialysis nephrology care duration for dialysis initiation: from analysis of Japanese dialysis initiation survey. Ther Apher Dial. 2012;16:54–62.
10. Nakai S. History of JSDT renal data registry (in Japanese). J Jpn Soc Dial Ther. 2010;43:119–52.
11. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27:363–73.
12. Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156–63.
13. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.
14. Nakayama M, Sato T, Miyazaki M, Matsushima M, Sato H, Taguma Y, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res. 2011;34:1106–10.
15. Nakayama M, Sato T, Sato H, Yamaguchi Y, Obara K, Kurihara I, et al. Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study. Clin Exp Nephrol. 2010;14:333–9.
16. Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial. 2012;16:11–53.
17. Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, et al. Chronic kidney disease Japan cohort (CKD-JAC) study: design and methods. Hypertens Res. 2008;31:1101–7.
18. Yamagata K, Makino H, Akizawa T, Iseki K, Itoh S, Kimura K, et al. Design and methods of a strategic outcome study for chronic kidney disease: frontier of renal outcome modifications in Japan. Clin Exp Nephrol. 2010;14:144–51.
19. Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K, Watanabe Y, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Apher Dial. 2009;13:457–504.
20. Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial Off Peer Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther. 2010;14:505–40.
21. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis. 1996;28:420–7.